openPR Logo
Press release

Engineered T Cells Market expected to scope $2,124 million by 2023 with More Effective Therapies for Cancer Safer

03-15-2019 09:11 AM CET | Health & Medicine

Press release from: Allied Market Research

Engineered T Cells Market

Engineered T Cells Market

Engineered T cells have enormous potential for effective treatment of cancer and other autoimmune diseases, which promotes adoption. In addition, advantages such as targeted therapies provided by artificial T cells relative to existing cancer therapies are expected to increase demand for engineered T cells.

Engineered T cells are also known as specifically modified T cells, which are designed for the treatment of autoimmune diseases, primary immune deficiencies, and cancer. Upon delivery, engineered T cells enable reduction of toxicities and inhibit antigen escape (inability of immune system to respond to an infectious agent). The engineered T cells assist immune system to overcome the immunosuppressive tumor microenvironments and target cancer cells for effective treatment.

Engineered T-Cells Market is projected to reach $2,124 million by 2023, growing at a CAGR of 46.5% from 2017 to 2023.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/4538?utm_source=sy

The major players profiled operating in the global engineered T cells market are
• Autolus Limited
• Bellicum Pharmaceuticals Inc.
• Cells Medica
• Elli Lilly and Company
• Gilead Sciences Inc.
• Juno Therapeutics
• Novartis AG
• Oxford Biomedica
• Pfizer Inc.
• Precision Bioscience.

Increase in global prevalence of cancer and surge in demand for innovative biopharmaceutical therapies is projected to drive the growth of the engineered T cells market. In addition, advantages offered by engineered T cells therapies such as targeted action and less side effects are expected to boost the demand for engineered T cells in future.

Chimeric antigen receptor (CAR) modified T cells segment is projected to dominate the market during the analysis period, due to surge in utilization of chimeric antigen receptor T cells in research facilities.

By application, lung cancer garnered the highest market share in 2016, and expected to dominate during the analysis period, owing to increase in incidence of lung cancer and high utilization of engineered T cells for the treatment of lung cancer.

Hospitals have the extensive use of engineered T cells, hence, it held the highest market value in 2016, and is expected to lead the market during the analysis period.

Make an Enquiry before Buy @ https://www.alliedmarketresearch.com/purchase-enquiry/4538?utm_source=sy

Key Findings of the Engineered T-cells Market:
• Chimeric antigen receptor modified T Cells segment accounted for more than half of the global market share in 2016.
• T cells receptor (TCR) segment is expected to grow at a highest CAGR.
• Asia-Pacific is anticipated to grow at the highest rate during the analysis period, followed by Europe.
• China and India are the major market shareholders in Asia-Pacific.

Geographically, North America dominated the market, accounting for approximately half of the overall market in 2016. This can be attributed to various factors such as presence of leading biotech companies and modern research facilities in the region. Furthermore, Asia-Pacific is projected to register the highest growth due to surge in number of biopharmaceutical companies and increase in acceptance of modern cancer treatments.

Access Full Summery @ https://www.alliedmarketresearch.com/engineered-T-cells-market?utm_source=sy

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Contact:

David Correa

5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States

Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975

help@alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Engineered T Cells Market expected to scope $2,124 million by 2023 with More Effective Therapies for Cancer Safer here

News-ID: 1656315 • Views: 288

More Releases from Allied Market Research

Epinephrine Autoinjector Market to Boost Revenue with Massive Growth
Global Epinephrine Autoinjector Market report it provides a vital recent industry data which covers in general market situation along with future scenario for industry around the Globe. It also consists of major data along with forecasts of a global market along with clear presentation of diagrams (charts and tables). According to a new report published by Allied Market Research, titled, “Epinephrine Autoinjector Market by Dosage (0.15mg, 0.3mg, and 0.5mg Dosage); Age
Enterprise Medical Image Viewers Market Challenges and New Trends
Global Enterprise Medical Image Viewers Market report it provides a vital recent industry data which covers in general market situation along with future scenario for industry around the Globe. It also consists of major data along with forecasts of a global market along with clear presentation of diagrams (charts and tables). According to a new report published by Allied Market Research, titled, “Enterprise Medical Image Viewers Market by Type (Devices and
Prenatal Vitamin Supplements Market Analysis of The Current and Emerging Trends
Global Prenatal Vitamin Supplements Market report it provides a vital recent industry data which covers in general market situation along with future scenario for industry around the Globe. It also consists of major data along with forecasts of a global market along with clear presentation of diagrams (charts and tables). According to a new report published by Allied Market Research, titled, “Prenatal Vitamin Supplements Market by Dosage Forms (Capsule, Powder and
Multiple Myeloma Market Analysis of Top industry Scenario
Global Multiple Myeloma Market report it provides a vital recent industry data which covers in general market situation along with future scenario for industry around the Globe. It also consists of major data along with forecasts of a global market along with clear presentation of diagrams (charts and tables). According to a new report published by Allied Market Research, titled, “Multiple Myeloma Market by Therapeutics Type [Chemotherapy and Other Drugs (Traditional

All 5 Releases


More Releases for Engineered

Market Leader - Engineered fluids (Fluorinated fluids) Market
The global market size of engineered fluids (fluorinated fluids) is projected to grow from USD 854 million in 2018 to USD 1,304 million by 2023, at a compound annual growth rate (CAGR) of 8.8% during the forecast period. The major driving factors for the market are the chemical inertness, low & high-temperature stability, non-flammability, and low toxicity properties of engineered fluids (fluorinated fluids). These properties enable engineered fluids (fluorinated fluids)
Engineered Fluids Market Size, Share, Development by 2023
Market Research Report Store offers a latest published report on Engineered Fluids Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 102 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. Click to view the full report TOC, figure and tables: https://www.globalinforesearch.com/global-engineered-fluids-market_p107129.html   Engineered Fluids is the premiere developer and
Engineered Foam Market Escalation 2025
Global Engineered Foam Market: Snapshot Engineered foam is a type of lightweight plastic that finds extensive usage in a wide range of end-use application. It is used in the manufacturing of waterproofing gaskets and shock absorption. In applications pertaining to sports and leisure activities, engineered foam is used in parts that require cushioning and lightweight impact such as flotation devices, helmet paddings, and wrestling mats. Request Sample Copy of the Report
Engineered Foam Market Key Segments & Forecast 2017 - 2025
Global Engineered Foam Market: Snapshot Engineered foam is a type of lightweight plastic that finds extensive usage in a wide range of end-use application. It is used in the manufacturing of waterproofing gaskets and shock absorption. In applications pertaining to sports and leisure activities, engineered foam is used in parts that require cushioning and lightweight impact such as flotation devices, helmet paddings, and wrestling mats. Solid and gaseous phases are combined
Advancements in Engineered Foam Market - 2024
Engineered foam is used in various applications such as insulation materials, packaging, wind energy, and cushioning of furniture. In engineered foam, solid and gas phases are combined at fast rate to give a resulting mixture that has a polymer matrix with bubbles or air channels incorporated in it. The gas, which is mixed with the foam, is called the blowing agent. It can be either chemical or physical. Physical blowing
Global Engineered Wood Market 2017-2023 Weyerhaeuser, Roseburg Forest, Huber Eng …
Engineered Wood Market Research 2017 A market study "Global Engineered Wood Market" examines the performance of the Engineered Wood market 2017. It encloses an in-depth Research of the Engineered Wood market state and the competitive landscape globally. This report analyzes the potential of Engineered Wood market in the present and the future prospects from various angles in detail. The Global Engineered Wood Market 2017 report includes Engineered Wood market Revenue, market Share,